Cargando…
Integrative proteomics reveals the role of E3 ubiquitin ligase SYVN1 in hepatocellular carcinoma metastasis
BACKGROUND: Tumor metastasis is a major factor for poor prognosis of hepatocellular carcinoma (HCC), but the relationship between ubiquitination and metastasis need to be studied more systematically. We analyzed the ubiquitinome of HCC in this study to have a more comprehensive insight into human HC...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504139/ https://www.ncbi.nlm.nih.gov/pubmed/34196494 http://dx.doi.org/10.1002/cac2.12192 |
_version_ | 1784581270983933952 |
---|---|
author | Ji, Feiyang Zhou, Menghao Sun, Zeyu Jiang, Zhengyi Zhu, Huihui Xie, Zhongyang Ouyang, Xiaoxi Zhang, Lingjian Li, Lanjuan |
author_facet | Ji, Feiyang Zhou, Menghao Sun, Zeyu Jiang, Zhengyi Zhu, Huihui Xie, Zhongyang Ouyang, Xiaoxi Zhang, Lingjian Li, Lanjuan |
author_sort | Ji, Feiyang |
collection | PubMed |
description | BACKGROUND: Tumor metastasis is a major factor for poor prognosis of hepatocellular carcinoma (HCC), but the relationship between ubiquitination and metastasis need to be studied more systematically. We analyzed the ubiquitinome of HCC in this study to have a more comprehensive insight into human HCC metastasis. METHODS: The protein ubiquitination levels in 15 HCC specimens with vascular invasion and 15 without vascular invasion were detected by ubiquitinome. Proteins with significantly different ubiquitination levels between HCCs with and without vascular invasion were used to predict E3 ubiquitin ligases associated with tumor metastasis. The topological network of protein substrates and corresponding E3 ubiquitin ligases was constructed to identify the key E3 ubiquitin ligase. Besides, the growth, migration and invasion ability of LM3 and HUH7 hepatoma cell lines with and without SYVN1 expression interference were measured by cell proliferation assay, subcutaneous tumor assay, umphal vein endothelium tube formation assay, transwell migration and invasion assays. Finally, the interacting proteins of SYVN1 were screened and verified by protein interaction omics, immunofluorescence, and immunoprecipitation. Ubiquitin levels of related protein substrates in LM3 and HUH7 cells were compared in negative control, SYVN1 knockdown, and SYVN1 overexpression groups. RESULTS: In this study, our whole‐cell proteomic dataset and ubiquitinomic dataset contained approximately 5600 proteins and 12,000 ubiquitinated sites. We discovered increased ubiquitinated sites with shorter ubiquitin chains during the progression of HCC metastasis. In addition, proteomic and ubiquitinomic analyses revealed that high expression of E3 ubiquitin‐protein ligase SYVN1 is related with tumor metastasis. Furthermore, we found that SYVN1 interacted with heat shock protein 90 (HSP90) and impacted the ubiquitination of eukaryotic elongation factor 2 kinase (EEF2K). CONCLUSIONS: The ubiquitination profiles of HCC with and without vascular invasion were significantly different. SYVN1 was the most important E3 ubiquitin‐protein ligase responsible for this phenomenon, and it was related with tumor metastasis and growth. Therefore, SYVN1 might be a potential therapeutic target for HCC. |
format | Online Article Text |
id | pubmed-8504139 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85041392021-10-18 Integrative proteomics reveals the role of E3 ubiquitin ligase SYVN1 in hepatocellular carcinoma metastasis Ji, Feiyang Zhou, Menghao Sun, Zeyu Jiang, Zhengyi Zhu, Huihui Xie, Zhongyang Ouyang, Xiaoxi Zhang, Lingjian Li, Lanjuan Cancer Commun (Lond) Original Articles BACKGROUND: Tumor metastasis is a major factor for poor prognosis of hepatocellular carcinoma (HCC), but the relationship between ubiquitination and metastasis need to be studied more systematically. We analyzed the ubiquitinome of HCC in this study to have a more comprehensive insight into human HCC metastasis. METHODS: The protein ubiquitination levels in 15 HCC specimens with vascular invasion and 15 without vascular invasion were detected by ubiquitinome. Proteins with significantly different ubiquitination levels between HCCs with and without vascular invasion were used to predict E3 ubiquitin ligases associated with tumor metastasis. The topological network of protein substrates and corresponding E3 ubiquitin ligases was constructed to identify the key E3 ubiquitin ligase. Besides, the growth, migration and invasion ability of LM3 and HUH7 hepatoma cell lines with and without SYVN1 expression interference were measured by cell proliferation assay, subcutaneous tumor assay, umphal vein endothelium tube formation assay, transwell migration and invasion assays. Finally, the interacting proteins of SYVN1 were screened and verified by protein interaction omics, immunofluorescence, and immunoprecipitation. Ubiquitin levels of related protein substrates in LM3 and HUH7 cells were compared in negative control, SYVN1 knockdown, and SYVN1 overexpression groups. RESULTS: In this study, our whole‐cell proteomic dataset and ubiquitinomic dataset contained approximately 5600 proteins and 12,000 ubiquitinated sites. We discovered increased ubiquitinated sites with shorter ubiquitin chains during the progression of HCC metastasis. In addition, proteomic and ubiquitinomic analyses revealed that high expression of E3 ubiquitin‐protein ligase SYVN1 is related with tumor metastasis. Furthermore, we found that SYVN1 interacted with heat shock protein 90 (HSP90) and impacted the ubiquitination of eukaryotic elongation factor 2 kinase (EEF2K). CONCLUSIONS: The ubiquitination profiles of HCC with and without vascular invasion were significantly different. SYVN1 was the most important E3 ubiquitin‐protein ligase responsible for this phenomenon, and it was related with tumor metastasis and growth. Therefore, SYVN1 might be a potential therapeutic target for HCC. John Wiley and Sons Inc. 2021-07-01 /pmc/articles/PMC8504139/ /pubmed/34196494 http://dx.doi.org/10.1002/cac2.12192 Text en © 2021 The Authors. Cancer Communications published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat‐sen University Cancer Center https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Ji, Feiyang Zhou, Menghao Sun, Zeyu Jiang, Zhengyi Zhu, Huihui Xie, Zhongyang Ouyang, Xiaoxi Zhang, Lingjian Li, Lanjuan Integrative proteomics reveals the role of E3 ubiquitin ligase SYVN1 in hepatocellular carcinoma metastasis |
title | Integrative proteomics reveals the role of E3 ubiquitin ligase SYVN1 in hepatocellular carcinoma metastasis |
title_full | Integrative proteomics reveals the role of E3 ubiquitin ligase SYVN1 in hepatocellular carcinoma metastasis |
title_fullStr | Integrative proteomics reveals the role of E3 ubiquitin ligase SYVN1 in hepatocellular carcinoma metastasis |
title_full_unstemmed | Integrative proteomics reveals the role of E3 ubiquitin ligase SYVN1 in hepatocellular carcinoma metastasis |
title_short | Integrative proteomics reveals the role of E3 ubiquitin ligase SYVN1 in hepatocellular carcinoma metastasis |
title_sort | integrative proteomics reveals the role of e3 ubiquitin ligase syvn1 in hepatocellular carcinoma metastasis |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504139/ https://www.ncbi.nlm.nih.gov/pubmed/34196494 http://dx.doi.org/10.1002/cac2.12192 |
work_keys_str_mv | AT jifeiyang integrativeproteomicsrevealstheroleofe3ubiquitinligasesyvn1inhepatocellularcarcinomametastasis AT zhoumenghao integrativeproteomicsrevealstheroleofe3ubiquitinligasesyvn1inhepatocellularcarcinomametastasis AT sunzeyu integrativeproteomicsrevealstheroleofe3ubiquitinligasesyvn1inhepatocellularcarcinomametastasis AT jiangzhengyi integrativeproteomicsrevealstheroleofe3ubiquitinligasesyvn1inhepatocellularcarcinomametastasis AT zhuhuihui integrativeproteomicsrevealstheroleofe3ubiquitinligasesyvn1inhepatocellularcarcinomametastasis AT xiezhongyang integrativeproteomicsrevealstheroleofe3ubiquitinligasesyvn1inhepatocellularcarcinomametastasis AT ouyangxiaoxi integrativeproteomicsrevealstheroleofe3ubiquitinligasesyvn1inhepatocellularcarcinomametastasis AT zhanglingjian integrativeproteomicsrevealstheroleofe3ubiquitinligasesyvn1inhepatocellularcarcinomametastasis AT lilanjuan integrativeproteomicsrevealstheroleofe3ubiquitinligasesyvn1inhepatocellularcarcinomametastasis |